Justin Stebbing

Justin was a Professor of Cancer Medicine and Oncology and a Consultant Oncologist at Imperial College, London, and is now a Visiting Professor there. He is a Fellow of the Royal College of Physicians, Editor-in-Chief of Springer Nature's cancer journal Oncogene, sits on the advisory Boards of a number of international cancer committees and chaired the BB biotech healthcare Trust board. Justin holds a first class degree in medicine from Trinity College, Oxford, and a PhD from Imperial, has published over 650 papers, and a member of the American Society of Clinical Investigation. He works as a consultant for Lansdowne and Vitruvian Partners.